The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction
Open accessAbstract
D iabetes mellitus and its associated complications are major health problems in the developed world.Diabetes mellitus is associated with an increased risk of cardiovascular disease (CVD) even in the presence of intensive glycemic control.Indeed, 75% of diabetic patients will die of CVD.Patients with type 1 and type 2 diabetes mellitus have an increased risk for the 3 major types of macrovascular disease (coronary heart disease, peripheral vascular disease, and stroke). 1 A striking feature of diabetic cardiovascular complications is the appearance of accelerated atherosclerosis, which anatomically resembles atherosclerosis in nondiabetic individuals but is more extensive and occurs at an earlier age.Substantial clinical and experimental evidence suggests that endothelial dysfunction is a crucial early step in the development of atherosclerosis.Evidence also suggests that it participates in plaque progression and the clinical emergence of cardiovascular events.Endothelial dysfunction is characterized by impaired endothelium-dependent vasodilation and "endothelial activation," which is associated with a proinflammatory, proliferative, and procoagulatory milieu that promotes initiation and complications of atherogenesis. 2 Endothelial dysfunction associated with insulin resistance appears to precede the development of overt hyperglycemia in patients with type 2 diabetes mellitus.3 Therefore, endothelial dysfunction may be a critical early target for the prevention of atherosclerosis and CVD in patients with diabetes mellitus or insulin resistance. 2 A synergistic cross talk exists among the conventional cardiovascular risk factors associated with diabetes mellitus, and such cross talk contributes to disruption of endothelial integrity and acceleration of atherosclerosis.However, the biochemical and cellular links between elevated blood glucose levels and endothelial dysfunction remain incompletely understood.This review will focus on the multifactorial nature of endothelial dysfunction in diabetes mellitus, the relationship between endothelial dysfunction and conventional cardiovascular risk factors, and the translational potential of molecular targets such as the AMP-activated protein kinase (AMPK) for treating endothelial dysfunction in diabetes mellitus. Endothelial Function and Cardiovascular Health Endothelial Function and Vascular HomeostasisOriginally considered to be simply a physical barrier between the blood and vascular wall, the endothelium is now recognized as the most important component of normal vascular homeostasis, because it serves to maintain the anticoagulant, antiplatelet, and fibrinolytic phenotypes of vascular cells.The maintenance of vascular homeostasis is accomplished through the release of numerous dilator and constrictor substances (the endothelium is regarded as a complex endocrine and paracrine organ 4 ; Figure 1).The most important factor released by the endothelium is nitric oxide (NO), originally identified as endothelium-derived relaxing factor.Other endothelium-derived vasodilators include prostacyclin, bradykinin, and an uncharacterized endothelium-derived hyperpolarizing factor.Prostacyclin acts synergistically with NO to inhibit platelet aggregation.Bradykinin stimulates release of NO, prostacyclin, and endothelium-derived hyperpolarizing factor to inhibit platelet aggregation.Bradykinin also stimulates production of tissue plasminogen activator and thus may play an important role in fibrinolysis.The endothelium also produces vasoconstrictor substances such as endothelin (the most potent endogenous vasoconstrictor identified to date), reactive oxygen species (ROS), prostaglandin H 2 (PGH 2 ), thromboxane A 2 (TXA 2 ), and angiotensin II.Angiotensin II is not only a vasoconstrictor but also a pro-oxidant that stimulates production of endothelin.Endothelin and angiotensin II promote proliferation of smooth muscle cells and in this way contribute to plaque formation.Large amounts of endothelin are produced by activated macrophages and vascular smooth muscle cells, the cellular components of atherosclerotic plaques.Because the endothelium plays a key role in vascular homeostasis, damage to this cellular layer will upset the balance between vasoconstriction and vasodilation, initiating a number of events/processes that promote or exacerbate atherosclerosis.These include endothelial permeabilization, platelet aggregation, leukocyte adhesion, and cytokine production. Assays of Endothelial Function in the ClinicAn improved understanding of the vascular biology of the endothelium and appreciation of the central role of the
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
8 retracted
Items 201–215 of 215
PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.
Erdmann, E., Dormandy, J., Wilcox, R., Massi‐Benedetti, M., & Charbonnel, B. H. (2007) · PubMed Central · Cited by 51
Nie, H., Wu, J., Zhang, M., Xu, J., & Zou, M. (2006) · Diabetes · doi:10.2337/db06-0505 · Cited by 51
Self-citationEndothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species
Kaehler, J., Sill, B., Koester, R., Mittmann, C., Orzechowski, H., Münzel, T. F., & Meinertz, T. (2002) · Clinical Science · doi:10.1042/cs103s176s · Cited by 51
Blackburn, P., Lemieux, I., Lamarche, B., Bergeron, J., Perron, P., Tremblay, G., Gaudet, D., & Després, J. (2007) · Diabetes Care · doi:10.2337/dc07-0272 · Cited by 50
Interactions Between Glucose and FFA Metabolism in Man
Saloranta, C., & Groop, L. (1996) · Diabetes/Metabolism Reviews · Cited by 37
Tripathy, D., Aljada, A., & Dandona, P. (2003) · Diabetologia · doi:10.1007/s00125-002-1027-y · Cited by 32
Tetrahydrobiopterin: Mediator of Endothelial Protection
Katušić, Z. S., & d’Uscio, L. V. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000121569.76931.0b · Cited by 29
Capaldo, B., Napoli, R., Marino, L. D., Picardi, A., Riccardi, G., & Saccà, L. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-5-893 · Cited by 29
Modification of Lipoproteins in Diabetes
Lopes-Virella, M. F., Klein, R. L., & Virella, G. (1996) · Diabetes/Metabolism Reviews · doi:10.1002/(sici)1099-0895(199603)12:1<15::aid-dmr153>3.0.co;2-0 · Cited by 27
Morinelli, T. A., Tempel, G. E., Jaffa, A. A., Silva, R. H., Naka, M., Folger, W. H., & Halushka, P. V. (1993) · Prostaglandins · doi:10.1016/0090-6980(93)90119-r · Cited by 24
Kautzky‐Willer, A., Tura, A., Winzer, C., Wagner, O. F., Ludvik, B. H., Hanusch‐Enserer, U., Prager, R., & Pacini, G. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00568.x · Cited by 21
Hyperglycemia promotes elevated generation of TXA2 in isolated rat uteri
Jawerbaum, A., Franchi, A. M., Gonzalez, E. T., Novaro, V., & Gimeno, M. A. F. (1995) · Prostaglandins · doi:10.1016/0090-6980(95)00086-p · Cited by 16
Voinea, M., Georgescu, A., Manea, A., Butoi, E. D., Mânduțeanu, I., Popov, D., & Simionescu, M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.004 · Cited by 14
Li, C. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830f4a44 · Cited by 7
Effects of Hyperglycemia on Vascular Endothelium Nitric Oxide Metabolism
Magill, S. B., & Dananberg, J. (1996) · Humana Press eBooks · doi:10.1007/978-1-4612-0231-8_11 · Cited by 6
Cited by
The Vascular Endothelium and Human Diseases
Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., & Nishigaki, I. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.7502 · Cited by 1,467
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
Guo, S. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0327 · Cited by 623
Eelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2018) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 572
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Metadata
- Authors
- Xu, J., & Zou, M.-H.
- Venue
- Circulation
- Published
- 2009-09-29
- Volume
- 120
- Issue
- 13
- Pages
- 1266-1286
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2134254489
- Cited by
- 353
- References
- 215
- FWCI
- 11.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.